
PHOENIX — Stepping down asthma medicines can be done safely and at a 
lower cost for patients, says a new Mayo Clinic study published recently
 in The Journal of Allergy and Clinical Immunology.
It is common 
for patients and doctors to test if taking less daily asthma medicine is
 safe — primarily because of the high cost of asthma medicine. However, 
deciding when to reduce daily asthma medicines can be challenging, and 
it would be helpful to understand the risks involved.
The study, 
led by Dr. Matthew Rank, an allergy and immunology specialist at Mayo 
Clinic in Arizona, analyzed asthma outcomes after patients stepped down 
their daily asthma medicines. The team studied more than 4,000 patients 
(adults and children) who were taking daily asthma medicines and focused
 their analysis on two groups: Patients who had stable asthma for at 
least one year who stayed on their same daily asthma medicine and 
patients who had stable asthma for at least one year who stepped down 
their daily asthma medicine.
Stepping down asthma medicines in 
patients who have had stable asthma for at least one year appears to be 
as safe as continuing the same level of medicines, the study found. Only
 11 percent of patients had problems with their asthma in the four to 
five months after stepping down their asthma medicines.
"Trying to
 reduce the daily asthma medicine speaks to the principle of using the 
least amount of medicine to control symptoms and prevent attacks," Rank 
said.
READ MORE